Liabilities / Assets
78th percentile
Higher debt load relative to assets than 78% of similar nonprofits.
990 • Fiscal year 2019 • EIN 45-2191464
Precomputed percentiles for this filing year versus similar nonprofits in the same peer cohort.
Liabilities / Assets
78th percentile
Higher debt load relative to assets than 78% of similar nonprofits.
Liabilities / Revenue
77th percentile
Higher debt load relative to revenue than 77% of similar nonprofits.
Net Margin
4th percentile
Higher net margin than 4% of similar nonprofits.
Top Officer Pay
Score unavailable
This filing does not contain officer compensation rows.
Asset Growth
6th percentile
Faster asset growth than 6% of similar nonprofits.
Revenue Growth
18th percentile
Faster revenue growth than 18% of similar nonprofits.
Assets
Down$173,782
Down $378,889 (-69%) from 2018
Net Assets
Down$155,195
Down $387,200 (-71%) from 2018
Liabilities
Up$18,587
Up $8,311 (+81%) from 2018
Revenue
Down$341,819
Down $139,869 (-29%) from 2018
Expenses
Up$729,019
Up $222,656 (+44%) from 2018
Net Income
Down-$387,200
Down $362,525 (-1469%) from 2018
This 2019 filing currently has summary financial data only. Detailed schedules, leadership, and program rows are not available for this filing yet.
To conduct research on the etiology, pathogenesis, biomarkers, and treatment of myalgic encephelomyelitis (me) formerly know as chronic fatigue syndrome (cfs). Our mission statement is to scientifically redefine me/cfs.
No mirrored PDF or thumbnail assets are attached yet.
Displayed year
2019 • Form 990Summary only. Only limited summary data is available for this year.